BLCONYSEOphthalmic GoodsFiscal year ends December 31
Bausch & Lomb Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.61+0.12 (+0.73%)
Close on Oct 19, 2026
- Market cap
- $5.93B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Operating margin
2.2%−5.4 pts over 5 years
Net margin
-7.1%−6.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.5% | +10.6% | +8.4% | – | |
| Operating income | -30.2% | -18.3% | -15.4% | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -5.6% | |
| Return on assets | – | – | -2.6% | |
| Current ratio | – | – | 1.55 | |
| Debt to equity | – | – | 0.78 | |
| Net debt to EBITDA | – | – | 8.74× | |
| Interest coverage | – | – | 0.3× | |
| Capex to revenue | – | 7.4% | 6.8% | |
| Diluted shares | – | 350M | 354M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Bausch & Lomb generated $1.75B from operations and spent $1.19B on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$1.75B
Used
$1.19B
Capital expenditure$1.19B100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-7.1%
×Asset turnover0.37×
×Equity multiplier2.13×
=Return on equity, FY2025-5.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -7.1% | 0.37× | 2.13× | -5.6% |
| FY2024 | -6.6% | 0.36× | 2.02× | -4.8% |
| FY2023 | -6.3% | 0.34× | 1.77× | -3.7% |
| FY2022 | 0.2% | 0.34× | 1.34× | 0.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$360.00M
- Cash generatingOperating cash flow above zero$283.00M
- Return on assets improvedROA up on the prior year-2.4% → -2.7%
- Earnings backed by cashOperating cash flow above net income$283.00M vs -$360.00M
- Less leverageLong-term debt to assets fell35.2% → 35.8%
- Better liquidityCurrent ratio rose1.60 → 1.55
- No dilutionShare count did not rise352M → 354M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.36 → 0.38